Summary New research indicates that administering blood pressure medication at bedtime offers no significant advantage over morning dosing for frail elderly individuals. While previous studies suggested potential cardiovascular benefits with bedtime dosing, this latest trial […]
Summary This article explores the increased risk of cardiovascular disease and death in adults with type 1 diabetes. It examines recent research highlighting smoking, obesity, and poor glucose control as key risk factors. Finally, it […]
Summary Diabetes deaths in the U.S. have fallen to their lowest levels in years, according to preliminary data from the CDC. This positive trend follows a surge in diabetes-related mortality during the COVID-19 pandemic. Experts […]
Summary This article explores a groundbreaking precision medicine approach that identifies subgroups within the obese population at high risk for diabetes and heart disease. This algorithm analyzes various factors, including body fat distribution and metabolic […]
Summary New research indicates GLP-1 drugs can significantly reduce BMI in children with severe obesity. This breakthrough offers hope for managing childhood obesity and its associated health risks. The study highlights the importance of comprehensive […]
Summary Roche is investing $550 million in its Indianapolis facility to establish a manufacturing hub for continuous glucose monitoring (CGM) systems. This investment aims to boost domestic production, create jobs, and improve access to diabetes […]
Summary Sana Biotechnology’s engineered islets allow insulin production without immunosuppressants, marking a major advancement in T1D treatment. This breakthrough utilizes deceased donor islets modified to evade immune detection, successfully producing insulin in a patient without […]
Summary This article explores exciting new advancements in islet transplantation for Type 1 diabetes. Scientists are developing innovative techniques to improve blood supply to transplanted islets, potentially leading to better blood sugar control and reducing […]
Summary Novo Nordisk will discontinue Levemir insulin by the end of 2026. This decision prompts a shift in diabetes management, emphasizing patient transition to alternative therapies. This article explores the discontinuation, its implications, and the […]
Summary Breakthrough T1D has unveiled an ambitious 10-year strategy to revolutionize type 1 diabetes care, focusing on precision medicine, early detection, and innovative treatments. The organization aims to accelerate breakthroughs in research, treatment, and prevention […]
© 2025 Newsguru LTD. All rights reserved.